InvestorsHub Logo
Followers 2
Posts 1472
Boards Moderated 0
Alias Born 07/20/2016

Re: None

Sunday, 07/02/2017 11:59:30 AM

Sunday, July 02, 2017 11:59:30 AM

Post# of 108192
Hopefully, Advaxis is going for an AA with the advanced an@l cancer study. At 6 months, 100% of patients who completed RT and received
treatment achieved a CR. At 34 months 89% remained disease free. The historical 3 year recurrence rate is around 45%. 4 of the patients are over the 3 year mark. If that doesn't qualify a treatment for an AA, I don't know what does.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News